Accrol Group Holdings PLC Notice of Results and Online Investor Presentation (0050X)
August 25 2020 - 1:00AM
UK Regulatory
TIDMACRL
RNS Number : 0050X
Accrol Group Holdings PLC
25 August 2020
25 August 2020
ACCROL GROUP HOLDINGS PLC
("Accrol", the "Group" or the "Company")
AIM: ACRL
NOTICE OF RESULTS AND INVESTOR PRESENTATION
For the year ended 30 April 2020
Notice of Results
Accrol, the UK's leading independent tissue converter, is
pleased to announce that its Audited Final Results for the year
ended 30 April 2020 will be published on Wednesday, 2 September
2020.
Investor Meet Company Presentation
Accrol is committed to communicating with all investors equally
and directly, to ensure that its strategy, business model and
performance are clearly understood. Accordingly, a part of the
Group's Final Results roadshow, an online presentation for all
interested parties will be hosted by management via the Investor
Meet Company ("IMC") platform. This will take place at 13.15 hours
on Friday, 4 September 2020.
To participate, you must register with IMC at
https://www.investormeetcompany.com/accrol-group-holdings-plc/register-investor
. Those who have already registered interest in Accrol with IMC
will be invited automatically.
Questions may be submitted ahead of the event, through the IMC
dashboard, or at any time during the live presentation, via the
"Ask a Question" function. Whilst the management may not be in a
position to answer all questions, the team will endeavour to answer
the most pertinent ones within the confines of the information
already disclosed to the market.
The presentation and Q&A responses will be available on the
IMC platform at the earliest opportunity post-event.
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Zeus Capital Limited (Nominated Adviser
& Broker)
Dan Bate / Jordan Warburton Tel: +44 (0) 161 831 1512
Dominic King / John Goold Tel: +44 (0) 203 829 5000
Liberum Capital Limited (Joint Broker) Tel: +44 (0) 20 3100 2222
Clayton Bush
Edward Thomas
Belvedere Communications Limited
Cat Valentine Tel: +44 (0) 7715 769 078
Keeley Clarke Tel: +44 (0) 7967 816 525
Llew Angus Tel: +44 (0) 7407 023 147
accrolpr@belvederepr.com
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading
tissue converter and supplier of toilet tissues, kitchen rolls and
facial tissues, as well as other tissue products, to major
discounters and grocery retailers throughout the UK. The business
operates from four sites in Lancashire:
-- A manufacturing, storage and distribution facility in Blackburn;
-- A storage and administrative centre in Blackburn;
-- A facial tissue plant, also in Blackburn; and
-- A manufacturing, storage and distribution facility in Leyland.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORPPUMCRUPUGCC
(END) Dow Jones Newswires
August 25, 2020 02:00 ET (06:00 GMT)
Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2024 to May 2024
Accrol (LSE:ACRL)
Historical Stock Chart
From May 2023 to May 2024